Browse government tenders, quotations, vacancies and documents across South Africa.
Showing opportunities with a recorded closing date that has not passed. Choose another status to browse historical records.
The National Department of Health is seeking to appoint a service provider to support the ongoing improvement and maintenance of health facilities across clinics, community health centres, and district hospitals. The service provider will focus on quality improvement initiatives, supportive supervision, mentorship, and patient-centred care implementation over a three-year period.
The Department of Health is seeking suppliers to provide a multivalent vaccine containing diphtheria toxoid, tetanus toxoid, acellular pertussis, inactivated polio vaccine, Haemophilus influenza b, and hepatitis B. The pack size has been amended from 1 x 10 prefilled syringes to 1 x 10 single dose vials.
The Department of Health requires a multidose vaccine containing at least 1000 CCID50 of live attenuated measles and 1000 CCID50 of live attenuated rubella virus per 0.5ml. The pack size has been changed from 1 x 50 vials to 1 x 1 vial, and the minimum order quantity has been reduced from 50 to 10 vials.
Adcock Ingram Critical Care (Pty) Ltd is approved to supply 75,000 units of an alternative brand of Oxytocin 5iu, Ergometrine 0.5mg injection, which is registered in the United Kingdom, due to a current stockout of the original product. This approval allows them to deliver the alternative product to the Department of Health.
Medi-Challenge (Pty) Ltd is approved to supply an alternative version of Mifepristone 200mg tablets, which are packaged in French or Romanian, due to the current unavailability of the original brand (Mifegyne 200mg). This approval allows the continuation of supply under the existing contract without interruption.
Austell Pharmaceuticals (Pty) Ltd is unable to supply its own brand of Enalapril 5mg scored tablets. The Department of Health has approved a replacement brand, Enalapril 5mg Arya 28's, to be supplied between August 2026 and 31 October 2026 as part of the ongoing contract for solid dosage forms.
The Department of Health has approved an emergency supply of 614,489 units of Luvigen tablets, which are an alternative brand to VULANTE TAB BOT 28 TND, for use in the national anti-retroviral programme.
The Department of Health is instructing suppliers to update the National Stock Number (NSN) for item 47, which is an inhaler device with mask and spacer for infants, from 189750639 to 189750638. This change applies to the current contract cycle and must be implemented by all relevant parties.
This is a government contract for the supply and delivery of anti-retroviral medicines to the Department of Health, covering the period from 1 December 2025 to 30 November 2028. The contract includes a brand name change for one product from ODINSTI DISPERSIBLE to MYLTEGA 10mg DISPERSIBLE TABLETS.
The Department of Health has revised the prices for certain medicines supplied by Austell Pharmaceuticals (Pty) Ltd. These updated prices are effective immediately and must be reflected in all relevant records. The changes apply to Allopurinol, Ibuprofen, and Paracetamol tablets.
A supplier may provide 28-tablet packs of Acetazolamide 250mg tablets, with a remaining volume of 264,430 units required over 27 months.
A supplier may provide 30-tablet packs of Clonidine 0.025mg tablets, with a remaining volume of 17,160 units required over 27 months.
